Euro-Med Laboratories Phil., Inc. (PSE:EURO)

Philippines flag Philippines · Delayed Price · Currency is PHP
0.8700
-0.0200 (-2.25%)
Last updated: Apr 22, 2025
17.57%
Market Cap 3.62B
Revenue (ttm) 5.80B
Net Income (ttm) 337.68M
Shares Out 4.11B
EPS (ttm) 0.08
PE Ratio 11.00
Forward PE n/a
Dividend 0.06 (6.90%)
Ex-Dividend Date Nov 14, 2024
Volume 5,000
Average Volume 15,000
Open 0.8900
Previous Close 0.8900
Day's Range 0.8700 - 0.8900
52-Week Range 0.7000 - 1.0100
Beta 0.48
RSI 48.91
Earnings Date Apr 16, 2025

About PSE:EURO

Euro-Med Laboratories Phil., Inc. manufactures and sells various pharmaceutical products in the Philippines and internationally. It manufactures and distributes large and small volume parenterals that are used as solvents for other drugs; sterile water for injection; and other solutions for ophthalmic, inhalation, irrigation, and dialysis. The company also offers specialty fluids comprising dialysis solutions for the treatment of acute or chronic renal failure; hemodialysis solution, a concentrated solution of electrolytes in water for injectio... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1988
Employees 1,604
Stock Exchange Philippine Stock Exchange
Ticker Symbol EURO
Full Company Profile

Financial Performance

In 2024, PSE:EURO's revenue was 5.80 billion, an increase of 10.11% compared to the previous year's 5.26 billion. Earnings were 337.68 million, an increase of 16.46%.

Financial Statements

News

There is no news available yet.